Human CXCL9/MIG Quantikine ELISA Kit
| Name | Human CXCL9/MIG Quantikine ELISA Kit |
|---|---|
| Supplier | R&D Systems |
| Catalog | DCX900 |
| Category | ELISA Kit |
| Prices | $509.00 |
| Sizes | 1 kit |
| Assay Type | Solid Phase Sandwich ELISA |
| Sample Type | Cell Culture Supernates (100 uL), Serum (100 uL), EDTA Plasma (100 uL), Heparin Plasma (100 uL) |
| Sensitivity | 11.3 pg/mL |
| Range | 31.2 - 2,000 pg/mL (Cell Culture Supernates, Serum, EDTA Plasma, Heparin Plasma) |
| Format | 96-well strip plate |
| Applications | ELISA |
| Species Reactivities | Human |
| Description | The Quantikine Human MIG Immunoassay is a 4.5 hour solid-phase ELISA designed to measure human MIG in cell culture supernates, serum, and plasma |
| Gene | CXCL9 |
| Supplier Page | Shop |
Product images
Product References
Left Ventricular Dysfunction and CXCR3 Ligands in Hypertension: From Animal - Left Ventricular Dysfunction and CXCR3 Ligands in Hypertension: From Animal
Altara R, Gu YM, Struijker-Boudier HA, Thijs L, Staessen JA, Blankesteijn WM. PLoS One. 2015 Oct 27;10(10):e0141394.
Increased CXCL9 serum levels in hepatitis C-related mixed cryoglobulinemia, with - Increased CXCL9 serum levels in hepatitis C-related mixed cryoglobulinemia, with
Antonelli A, Fallahi P, Ferrari SM, Colaci M, Giuggioli D, Saraceno G, Benvenga S, Ferri C. J Interferon Cytokine Res. 2013 Dec;33(12):739-45.
BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and - BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and
Pranzatelli MR, Tate ED, McGee NR, Travelstead AL, Colliver JA, Ness JM, Ransohoff RM. J Neuroinflammation. 2013 Jan 16;10:10.
Expression of CXCR3 and its ligands CXCL9, -10 and -11 in paediatric - Expression of CXCR3 and its ligands CXCL9, -10 and -11 in paediatric
Pranzatelli MR, Tate ED, McGee NR, Travelstead AL, Verhulst SJ, Ransohoff RM. Clin Exp Immunol. 2013 Jun;172(3):427-36.
Serum CXCL9 levels are associated with tumor progression and treatment outcome in - Serum CXCL9 levels are associated with tumor progression and treatment outcome in
Hsin LJ, Kao HK, Chen IH, Tsang NM, Hsu CL, Liu SC, Chang YS, Chang KP. PLoS One. 2013 Nov 21;8(11):e80052.
Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell - Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell
Knoblach T, Grandel B, Seiler J, Nevels M, Paulus C. PLoS Pathog. 2011 Apr;7(4):e1002016.
Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive - Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive
Antonelli A, Ferrari SM, Frascerra S, Galetta F, Franzoni F, Corrado A, Miccoli M, Benvenga S, Paolicchi A, Ferrannini E, Fallahi P. Cytokine. 2011 Aug;55(2):288-93.
Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of - Expression of CXCL9, -10, -11, and CXCR3 in the tear film and ocular surface of
Yoon KC, Park CS, You IC, Choi HJ, Lee KH, Im SK, Park HY, Pflugfelder SC. Invest Ophthalmol Vis Sci. 2010 Feb;51(2):643-50.
Villitis of unknown etiology is associated with a distinct pattern of chemokine - Villitis of unknown etiology is associated with a distinct pattern of chemokine
Kim MJ, Romero R, Kim CJ, Tarca AL, Chhauy S, LaJeunesse C, Lee DC, Draghici S, Gotsch F, Kusanovic JP, Hassan SS, Kim JS. J Immunol. 2009 Mar 15;182(6):3919-27.
The imbalance in serum concentration of Th-1- and Th-2-derived chemokines as one - The imbalance in serum concentration of Th-1- and Th-2-derived chemokines as one
Narbutt J, Lesiak A, Sysa-Jedrzeiowska A, Zakrzewski M, Bogaczewicz J, Stelmach I, Kuna P. Mediators Inflamm. 2009;2009:269541.